Alexion Pharmaceuticals Inc.

ALXN

$150.94

+66.0% (1 year change)

Avg closing price

Price range

Market Cap

$36.2 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$1.59 Billion

Total revenue in the last quarter.

Net Income

$536 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$2.72

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

59.93x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$647 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

News

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MDCA, FFG, ALXN, NK, HLIX; Shareholders Are Encouraged to Contact the Firm

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MDCA, FFG, ALXN, NK, HLIX; Shareholders Are Encouraged to Contact the Firm

NEW YORK , Feb. 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: MDC Partners Inc. (NASDAQ: MDCA ) concerning pot...

Benzinga Benzinga, 2 months ago
Alexion Pharmaceuticals (NASDAQ:ALXN) Releases Earnings Results, Beats Estimates By $0.40 EPS

Alexion Pharmaceuticals (NASDAQ:ALXN) Releases Earnings Results, Beats Estimates By $0.40 EPS

Alexion Pharmaceuticals (NASDAQ:ALXN) released its earnings results on Wednesday. The biopharmaceutical company reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.56 by...

Transcript Daily Transcript Daily, 3 months ago
Alexion Pharmaceuticals (ALXN) Set to Announce Earnings on Thursday

Alexion Pharmaceuticals (ALXN) Set to Announce Earnings on Thursday

Alexion Pharmaceuticals (NASDAQ:ALXN) will be posting its quarterly earnings results before the market opens on Thursday, February 4th. Analysts expect Alexion Pharmaceuticals to post earnings of $...

Transcript Daily Transcript Daily, 3 months ago